AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
A controlled trial comparing two doses of cyclosporine in conjunction withmycophenolate mofetil and corticosteroids
Authors: de Sevaux, RGL Gregoor, PJHS Hene, RJ Hoitsma, AJ Vos, P Weimar, W van Gelder, T Hilbrands, LB
Citation: Rgl. De Sevaux et al., A controlled trial comparing two doses of cyclosporine in conjunction withmycophenolate mofetil and corticosteroids, J AM S NEPH, 12(8), 2001, pp. 1750-1757
Current issues in therapeutic drug monitoring of mycophenolic acid: Reportof a roundtable discussion
Authors: Shaw, LM Holt, DW Oellerich, M Meiser, B van Gelder, T
Citation: Lm. Shaw et al., Current issues in therapeutic drug monitoring of mycophenolic acid: Reportof a roundtable discussion, THER DRUG M, 23(4), 2001, pp. 305-315
Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid
Authors: van Gelder, T Klupp, J Barten, MJ Christians, U Morris, RE
Citation: T. Van Gelder et al., Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid, THER DRUG M, 23(2), 2001, pp. 119-128
Assessment of mechanisms of action of immunosuppressive drugs using novel whole blood assays
Authors: Barten, MJ Gummert, JF van Gelder, T Shorthouse, R Morris, RE
Citation: Mj. Barten et al., Assessment of mechanisms of action of immunosuppressive drugs using novel whole blood assays, TRANSPLAN P, 33(3), 2001, pp. 2119-2120
The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation
Authors: Hesse, CJ Vantrimpont, P van Riemsdijk-van Overbeeke, IC van Gelder, T Balk, AHMM Weimar, W
Citation: Cj. Hesse et al., The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation, TRANSPLAN P, 33(3), 2001, pp. 2163-2164
Mycophenolate mofetil pharmacodynamics and pharmacokinetics correlate withrejection score in a BN-to-LEW heterotopic heart transplant model
Authors: Klupp, J van Gelder, T Dambrin, C Regieli, J Boeke, K Billingham, ME Morris, RE
Citation: J. Klupp et al., Mycophenolate mofetil pharmacodynamics and pharmacokinetics correlate withrejection score in a BN-to-LEW heterotopic heart transplant model, TRANSPLAN P, 33(3), 2001, pp. 2170-2171
New approach in drug development: Whole blood pharmacodynamic assays reflect biological activities of tacrolimus
Authors: Klupp, J Dambrin, C Regieli, J van Gelder, T Shorthouse, R Morris, RE
Citation: J. Klupp et al., New approach in drug development: Whole blood pharmacodynamic assays reflect biological activities of tacrolimus, TRANSPLAN P, 33(3), 2001, pp. 2172-2172
T-cell reactivity during azathioprine therapy compared with mycophenolate mofetil therapy
Authors: van Besouw, NM van der Mast, BJ de Kuiper, P Gregoor, PJHS Vaessen, LMB IJzermans, JNM van Gelder, T Weimar, W
Citation: Nm. Van Besouw et al., T-cell reactivity during azathioprine therapy compared with mycophenolate mofetil therapy, TRANSPLAN P, 33(3), 2001, pp. 2239-2240
New mechanisms of action of mycophenolate mofetil in transplant recipientsby assessment of its pharmacodynamics
Authors: Barten, MJ van Gelder, T Gummert, JF Shorthouse, R Boeke, K Billingham, ME Morris, RE
Citation: Mj. Barten et al., New mechanisms of action of mycophenolate mofetil in transplant recipientsby assessment of its pharmacodynamics, TRANSPLAN P, 33(3), 2001, pp. 2254-2255
ATP-binding cassette transporters and calcineurin inhibitors: Potential clinical implications
Authors: van Gelder, T Klupp, J Sawamoto, T Christians, U Morris, RE
Citation: T. Van Gelder et al., ATP-binding cassette transporters and calcineurin inhibitors: Potential clinical implications, TRANSPLAN P, 33(3), 2001, pp. 2420-2421
Proteinuria and death risk in the renal transplant population
Authors: Roodnat, JI Mulder, PGH Rischen-Vos, J van Riemsdijk, IC van Gelder, T Zietse, R Ijzermans, JNM Weimar, W
Citation: Ji. Roodnat et al., Proteinuria and death risk in the renal transplant population, TRANSPLAN P, 33(1-2), 2001, pp. 1170-1171
Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression.
Authors: van der Mast, BJ van Besouw, NM de Kuiper, P Vaessen, LMB Gregoor, PJHS IJzermans, JNM van Gelder, T Claas, FHJ Weimar, W
Citation: Bj. Van Der Mast et al., Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression., TRANSPLANT, 72(5), 2001, pp. 873-880
Proteinuria after renal transplantation affects not only graft survival but also patient survival
Authors: Roodnat, JL Mulder, PGH Rischen-Vos, J van Riemsdijk, IC van Gelder, T Zietse, R Ijzermans, JNM Weimar, W
Citation: Jl. Roodnat et al., Proteinuria after renal transplantation affects not only graft survival but also patient survival, TRANSPLANT, 72(3), 2001, pp. 438-444
Reassuring effect of pravastatin on natural killer cell activity in stablerenal transplant patients
Authors: Vaessen, LMB van Miert, PPMC van Gelder, T IJzermans, JNM Weimar, W
Citation: Lmb. Vaessen et al., Reassuring effect of pravastatin on natural killer cell activity in stablerenal transplant patients, TRANSPLANT, 71(8), 2001, pp. 1175-1179
Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro
Authors: Barten, MJ Gummert, JF van Gelder, T Shorthouse, R Morris, RE
Citation: Mj. Barten et al., Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro, J IMMUNOL M, 253(1-2), 2001, pp. 95-112
A longitudinal study of TGF-beta(1) protein levels in renal allograft recipients converted from CsA to MMF or AZA
Authors: van der Mast, BJ van Besouw, NM de Kuiper, P Vaessen, LMB IJzermans, JNM van Gelder, T Weimar, W
Citation: Bj. Van Der Mast et al., A longitudinal study of TGF-beta(1) protein levels in renal allograft recipients converted from CsA to MMF or AZA, CLIN TRANSP, 14(1), 2000, pp. 66-69
The difficult diagnostic approach of the intraperitoneal mesothelioma
Authors: Yoo, SM ten Tije, AJ van der Harst, E van Gelder, T
Citation: Sm. Yoo et al., The difficult diagnostic approach of the intraperitoneal mesothelioma, NETH J MED, 57(6), 2000, pp. 224-228
Mycophenolate mofetil, Cellcept (R), a new immunosuppressive drug with great potential in internal medicine
Authors: Gregoor, PJHS van Gelder, T Weimar, W
Citation: Pjhs. Gregoor et al., Mycophenolate mofetil, Cellcept (R), a new immunosuppressive drug with great potential in internal medicine, NETH J MED, 57(6), 2000, pp. 233-246
Switching antiretroviral therapy from an enzyme-inducing drug
Authors: van Gelder, T Gregoor, PJHS Weimar, W
Citation: T. Van Gelder et al., Switching antiretroviral therapy from an enzyme-inducing drug, THER DRUG M, 22(5), 2000, pp. 639-639
The impact of donor age on renal graft survival
Authors: Roodnat, JI Zietse, R Mulder, PGH Rischen-Vos, J van Gelder, T Ijzermans, JNM Weimar, W
Citation: Ji. Roodnat et al., The impact of donor age on renal graft survival, TRANSPLAN P, 32(1), 2000, pp. 136-138
Pharmacodynamics of mycophenolic acid in heart allograft recipients: Correlation of lymphocyte proliferation and activation with pharmacokinetics andgraft histology
Authors: Gummert, JF Barten, MJ van Gelder, T Billingham, ME Morris, RE
Citation: Jf. Gummert et al., Pharmacodynamics of mycophenolic acid in heart allograft recipients: Correlation of lymphocyte proliferation and activation with pharmacokinetics andgraft histology, TRANSPLANT, 70(7), 2000, pp. 1038-1049
Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced
Authors: van Besouw, NM van der Mast, BJ de Kuiper, P Gregoor, PJHS Vaessen, LMB Ijzermans, JNM van Gelder, T Weimar, W
Citation: Nm. Van Besouw et al., Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced, TRANSPLANT, 70(1), 2000, pp. 136-143
Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction
Authors: Gregoor, PJHS van Gelder, T van Besouw, NM van der Mast, BJ Ijzermans, JNM Weimar, W
Citation: Pjhs. Gregoor et al., Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction, TRANSPLANT, 70(1), 2000, pp. 143-148
Response: Randomized, concentration-controlled trial of MMF after kidney transplantation
Authors: van Gelder, T
Citation: T. Van Gelder, Response: Randomized, concentration-controlled trial of MMF after kidney transplantation, TRANSPLANT, 69(8), 2000, pp. 1753-1754
Functional responses of T cells blocked by anti-CD25 antibody therapy during cardiac rejection
Authors: Baan, CC van Gelder, T Balk, AHMM Knoop, CJ Holweg, CTJ Maat, LPWM Weimar, W
Citation: Cc. Baan et al., Functional responses of T cells blocked by anti-CD25 antibody therapy during cardiac rejection, TRANSPLANT, 69(3), 2000, pp. 331-336
Risultati: 1-25 | 26-39